EFTUD1 antibody
Principal name
EFTUD1 antibody
Alternative names for EFTUD1 antibody
Elongation factor Tu GTP-binding domain-containing protein 1, EFL1, FAM42A, Elongation factor-like 1, Protein FAM42A
Available reactivities
Available hosts
Available applications
Paraffin Sections (P), Western blot / Immunoblot (WB)
Background of EFTUD1 antibody
- Kit Component:
- - KN305052G1, Eftud1 gRNA vector 1 in pCas-Guide vector
- KN305052G2, Eftud1 gRNA vector 2 in pCas-Guide vector
- KN305052D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
EFTUD1 antibody (C-term) (Cat. #AP51382PU-N) immunohistochemistry analysis in formalin fixed and paraffin embedded human skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the EFTUD1 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
EFTUD1 Antibody (C-term) (Cat. #AP51382PU-N) western blot analysis in mouse spleen tissue lysates (35µg/lane).This demonstrates the EFTUD1 antibody detected the EFTUD1 protein (arrow).
EFTUD1 Antibody (C-term) (Cat. #AP51382PU-N) western blot analysis in Hela cell line lysates (35µg/lane).This demonstrates the EFTUD1 antibody detected the EFTUD1 protein (arrow).
EFTUD1 Antibody (C-term) (Cat. #AP51382PU-N) flow cytometric analysis of Hela cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
Host: Rabbit; Target Name: EFTUD1; Sample Tissue: HepG2 Whole Cell lysates; Antibody Dilution: 1.0ug/ml
Host: Rabbit; Target Name: EFTUD1; Sample Tissue: HepG2 Whole Cell lysates; Antibody Dilution: 1.0ug/ml
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP51382PU-N | EFTUD1 (C-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu, Ms | P, WB |
0.4 ml /
€370.00
|
|
| OriGene Technologies GmbH | |||||||
 +3 additional images |
Highly validated antibody! |
||||||
| TA332232 | EFTUD1 antibody |
||||||
| Rabbit Polyclonal Anti-EFTUD1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Hu, Ms, Rb, Rt, Ze | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA332233 | EFTUD1 antibody |
||||||
| Rabbit Polyclonal Anti-EFTUD1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Hu, Ms, Rb, Rt | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC222549L2V | Lenti ORF particles, EFTUD1 (mGFP-tagged)-Human elongation factor Tu GTP binding domain containing 1 (EFTUD1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€2,215.00
|
|
| OriGene Technologies, Inc. | ||
| RC222549L1V | Lenti ORF particles, EFTUD1 (Myc-DDK-tagged)-Human elongation factor Tu GTP binding domain containing 1 (EFTUD1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,999.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216621L2V | Lenti ORF particles, Eftud1 (GFP-tagged) - Mouse elongation factor Tu GTP binding domain containing 1 (Eftud1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,999.00
|
|
| OriGene Technologies, Inc. | ||
| MR211672L2V | Lenti ORF particles, Eftud1 (GFP-tagged) - Mouse elongation factor Tu GTP binding domain containing 1 (Eftud1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,834.00
|
|
| OriGene Technologies, Inc. | ||
| MR216621L1V | Lenti ORF particles, Eftud1 (Myc-DDK-tagged) - Mouse elongation factor Tu GTP binding domain containing 1 (Eftud1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,803.00
|
|
| OriGene Technologies, Inc. | ||
| MR211672L1V | Lenti ORF particles, Eftud1 (Myc-DDK-tagged) - Mouse elongation factor Tu GTP binding domain containing 1 (Eftud1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,648.00
|
|
| OriGene Technologies, Inc. | ||
